Calcium supplements increase risk of myocardial infarction

Journal of Bone and Mineral Research

Volumn 30, Issue 2, 2015, Pages 389-390

  Bolland, Mark J ^a   Grey, Andrew ^a   Avenell, Alison ^b   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D; BONE DENSITY CONSERVATION AGENT; CALCIUM INTAKE;

ANGINA PECTORIS; CALCIUM BLOOD LEVEL; CARDIAC PATIENT; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LETTER; MINERAL SUPPLEMENTATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SEX DIFFERENCE; BLOOD; CALCIUM INTAKE; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; FEMALE; MORTALITY; POSTMENOPAUSE; THERAPEUTIC USE;

BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; CORONARY DISEASE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; POSTMENOPAUSE;

EID: 84921737946     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2357     Document Type: Letter

References (15)

1. Lewis JR, Radavelli-Bagatini S, Rejnmark L, et al. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res. Epub 2014 Jul 10. DOI: 10.1002/jbmr.2311.
2. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction,cardiovascular events: meta-analysis. BMJ. 2010;341:c3691.
3. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040.
4. Reid IR, Bolland MJ, Avenell A, Grey A. Cardiovascular effects of calcium supplementation. Osteoporos Int. 2011;22:1649-58.
5. Bolland MJ, Grey A, Reid IR. Calcium supplements and cardiovascular risk: 5 years on. Ther Adv Drug Saf. 2013;4:199-210.
6. Sun X, Ioannidis JP, Agoritsas T, Alba AC, Guyatt G. How to use a subgroup analysis: users' guide to the medical literature. JAMA. 2014;311:405-11.
7. Montori VM, Permanyer-Miralda G, Ferreira-Gonzalez I, et al. Validity of composite end points in clinical trials. BMJ. 2005;330:594-6.
8. Reid IR, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med. 2006;119:777-85.
9. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004;19:370-8.
10. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;2:307-20.
11. Jamal SA, Vandermeer B, Raggi P, et al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet. 2013;382:1268-77.
12. Medicines and Healthcare Products Regulatory Agency (MHRA). Healthcare Products Regulatory Agency (MHRA). Strontium ranelate (Protelos): risk of serious cardiac disorders - Restricted indications, new contraindications, and warnings. Drug Safety Update. 2013;6:S1.
13. Reid IR, Bolland MJ, Grey A. Does calcium supplementation increase cardiovascular risk? Clin Endocrinol (Oxf). 2010;73:689-95.
14. Slinin Y, Blackwell T, Ishani A, Cummings SR, Ensrud KE. Serum calcium, phosphorus and cardiovascular events in post-menopausal women. Int J Cardiol. 2011;149:3350.
15. Reid IR, Bolland MJ. Calcium risk-benefit updated - new WHI analyses. Maturitas. 2014;77:1-3.